Be sure to check our sister interview main ratings news website

VAL

Hardman & Co

ValiRx Plc VAL401 is going forward

15th April 2019

ValiRx Plc (LON:VAL)  is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment of cancer. The company has two leading assets: VAL201 (Phase I/II) – a peptide

Hardman & Co

ValiRx Plc VAL401 Phase II trial completed

1st November 2018

ValiRx Plc (LON:VAL) is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment of cancer. The company’s two leading assets are in clinical trials: VAL201 (Phase

Hardman & Co

ValiRx Plc Clinical efficacy of VAL401

18th December 2017

ValiRx Plc (LON:VAL) is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment of cancer, associated biomarkers and companion diagnostics. The company’s two leading assets are

Hardman & Co

ValiRx Progressing all the pipeline

6th October 2017

ValiRx Plc (LON:VAL) is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment of cancer, associated biomarkers and companion diagnostics. The company’s two leading assets are

Hardman & Co

ValiRx Positive early data from VAL401

2nd October 2017

ValiRx Plc (LON:VAL) is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment of cancer, associated biomarkers and companion diagnostics. The company’s two leading assets are

Hardman & Co

ValiRx Plc GeneICE and VAL101 progress

13th September 2017

ValiRx Plc (LON:VAL) is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment of cancer, associated biomarkers and companion diagnostics. The company’s two leading assets are

Hardman & Co

ValiRx Plc Developing novel cancer therapies

1st June 2017

ValiRx Plc (LON:VAL) is a clinical-stage bio-pharmaceutical company focused on the development of therapeutics for the treatment of cancer, associated biomarkers and companion diagnostics. The company’s two leading assets are

Q&As

Tekmar Group plc

Tekmar Group Plc: Bold Strategy, M&A, and Strong Pipeline Drive Growth (CEO Q&A)

Tekmar Group Plc's CEO, Richard Turner, discusses the company's refreshed strategy, growth plan, and positive financial results in an exclusive interview.
Hardman & Co

Volta Finance: Strong 2024, Positive 2025 outlook (LON:VTA)

Discover insights from Hardman & Co's exclusive interview with Volta Finance Ltd (LON:VTA) on their impressive performance and outlook for 2025.
Hardman & Co

Real Estate Credit Investments: Opportunities, risks and market trends

Real Estate Credit Investments Ltd (LON:RECI) discussed by Hardman & Co’s Mark Thomas. Exclusive insights on private credit growth and potential threats.
Firering Strategic MineralS PLC

Firering Strategic Minerals: Kiln commissioning & production update (LON:FRG)

Firering Strategic Minerals plc (LON:FRG) Director Vassilios Carellas discusses gasifier commissioning, first production, and upcoming milestones.
EDX Medical Group plc

EDX Medical’s Prof. Chris Evans on Prostate Cancer Breakthrough & Future Plans (AQSE:EDX)

EDX Medical Group plc founder, Professor Chris Evans, discusses the company's new super-test for prostate cancer and its innovative approach to diagnostics.
itim Group plc

itim Group CFO Ian Hayes on 260% EBITDA Growth and Future Prospects (Video)

Funds

Why real estate credit is winning institutional capital

Discover the compelling investment story of real estate credit in a volatile market. Learn how this asset class offers attractive returns and downside protection.
Volta Finance

Middle market CLOs gain momentum as new investor appetite grows

Middle market CLOs are on the rise in structured credit, offering strong yields and resilience. Discover how institutional demand is reshaping the landscape!

Emerging Markets heat up as investors shift from US assets

Discover the resurgence of emerging markets as investors pivot towards undervalued assets in Latin America, Eastern Europe, and Asia amidst shifting dynamics.
Team plc

Trump’s tariff blitz sends shockwaves through global markets

President Trump's latest trade moves have sent shockwaves through global markets. Learn how his tariff tactics are impacting international trade dynamics.
Fidelity Japan Trust

Industrial momentum and gaming gains power Nikkei’s advance

Fidelity European Trust

Europe’s markets surge as inflation cools

European markets surged on Tuesday ahead of key U.S. trade measures, boosted by cooling inflation and strong performance from German industry stocks.

Presentations

Challenger Energy

Challenger Energy plc Transforming Exploration Potential into a Frontier Opportunity

Discover Challenger Energy Group's visionary approach to exploration in Uruguay and strategic partnerships with Chevron in this detailed presentation by CEO Eytan Uliel. High-growth potential for investors.
Cerillion

Cerillion PLC Annual Results 2024 ‘Record Highs’, Louis Hall CEO

Norcros Plc

Norcros Plc CEO and CFO Present Interim Results to 30 September 2024 (LON:NXR)

Ilika plc

Ilika plc: A New Era in Solid-State Battery Innovation – 2024 Investor Presentation

Time Finance plc

Time Finance PLC Strong Growth and Strategic Progress: A Message from CEO Ed Rimmer

Pulsar Helium Inc

Pulsar Helium Inc.: A Pioneering Force in the Helium Industry with High-Concentration Discoveries

Broker Talk

Drax Group plc

Drax Group Secures Key Biomass Support Deal – Longspur Research

Drax Group secures government support for biomass operations in the UK, ensuring financial strength and decarbonisation goals. Gain share mechanism offers potential profitability.
Hercules Site Services plc

Hercules Site Services Strengthens Growth Prospects Following Strategic Divestment – Equity Development

Hercules Site Services successfully completes divestment of Suction Excavators business, focusing on high-growth opportunities. Streamlined for expansion.
Jubilee Metals Group plc

Jubilee Metals Powers Forward with Copper Expansion – Zeus Capital

Jubilee Metals Group Plc (LON:JLP) is on track to boost its copper production in Zambia with stable power supply and strategic material purchases, as per Zeus Capital.
itim Group plc

itim Group’s Strong FY24 Performance Sparks Upgraded Forecasts – Zeus Capital

Beeks Financial Cloud Group Plc: Leading the Way with Nasdaq Partnership – Canaccord Genuity

Beeks Financial Cloud Group Plc secures Nasdaq as the latest customer for its Exchange Cloud service, solidifying its leadership in low-latency solutions.

Agronomics: Unlocking the Future of Cellular Agriculture – Cavendish

Agronomics Limited (LON:ANIC) shapes the future of sustainable food production with strategic investments in cellular agriculture. Cavendish report highlights its progress in 2024.

© 2025 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.